The following six cancer-related signaling pathways: p53/DNA damage, NF-кB, MAPK/ERK, ATF2/ATF3/ATF4, cAMP/PKA and MEF2 were selected, whose activities differed by more than two-fold. This evidence concerns the gene TP53 and cancer.